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Recent discoveries suggest that a novel second messenger, bis-
(335)-cyclic di-GMP (c-diGMP), is extensively used by bacteria to
control multicellular behavior. Condensation of two GTP to the
dinucleotide is catalyzed by the widely distributed diguanylate
cyclase (DGCorGGDEF) domain that occurs in various combinations
with sensory andor regulatory modules. The crystal structure of
the unorthodox response regulator PleD from Caulobacter cres-
centus, which consists of two CheY-like receiver domains and a
DGC domain, has been solved in complex with the product c-
diGMP. PleD forms a dimer with the CheY-like domains (the stem)
mediating weak monomer–monomer interactions. The fold of the
DGC domain is similar to adenylate cyclase, but the nucleotide-
binding mode is substantially different. The guanine base is H-
bonded to Asn-335 and Asp-344, whereas the ribosyl and -phos-
phate moieties extend over the 2-3-hairpin that carries the
GGEEF signature motif. In the crystal, c-diGMP molecules are
crosslinking active sites of adjacent dimers. It is inferred that, in
solution, the two DGC domains of a dimer align in a two-fold
symmetric way to catalyze c-diGMP synthesis. Two mutually in-
tercalated c-diGMP molecules are found tightly bound at the
stem–DGC interface. This allosteric site explains the observed
noncompetitive product inhibition. We propose that product inhi-
bition is due to domain immobilization and sets an upper limit for
the concentration of this second messenger in the cell.
allosteric regulation  signal transduction  x-ray crystallography
Cyclic nucleotides like cAMP or cGMP have been recognizedas important low-molecular-weight signaling molecules. Al-
though bacterial pathogens can interfere with cGMP signaling of
their eukaryotic host cells (1), prokaryotes in general do not
seem to use cGMP for signaling. In contrast, the cyclic dinucle-
otide bis-(335)-cyclic diGMP (c-diGMP) has been shown to
regulate cell surface-associated traits and community behavior-
like biofilm formation in a number of bacterial species (2–5). The
general importance of c-diGMP is underscored by the omni-
presence of the diguanylate cyclase (DGC) domain (hitherto
named GGDEF or DUF1) in bacterial genomes, where it occurs
in various combinations with other sensory andor regulatory
modules (6, 7). Despite the wide distribution and obvious
regulatory relevance of DGC proteins, structural and functional
information about this class of regulators is largely missing.
In Caulobacter crescentus, pole remodeling during develop-
ment is regulated by several polar sensor histidine kinases, which
control the DGC activity of the response regulator PleD (8, 9).
PleD is composed of a CheY-like receiver domain (D1), a
CheY-like adapter domain (D2), and a DGC domain. Upon
phosphorylation of D1, activated PleD sequesters to the differ-
entiating pole, where it catalyzes the conversion of twomolecules
of GTP to c-diGMP (10). Thus, by coupling of activity and
subcellular localization, the PleD readout is controlled in time
and space. The conformational changes invoked by phosphory-
lation of response regulator receiver (RRR) domains have been
studied thoroughly on CheY (11) and other single domain
receiver proteins (for a review, see ref. 12). Little, however, is
known about how these alterations are transmitted to the
effector protein or domain, and only few intact multidomain
response regulators have been analyzed structurally. Distinct
mechanisms of activation, such as relief of active site obstruction
[CheB (11, 13)], dimerization [DrrB, DrrD (14)], or both [NarL
(15)], have been proposed.
Here, we report the structure of full-length PleD, which allows
conclusions to be drawn regarding its mechanism of activation
and product inhibition. Also, by providing a detailed view on the
enzyme–product interactions, our study offers insight into the
catalytic mechanism of this widespread family of regulatory
proteins.
Materials and Methods
Overexpression and Purification. Full-length PleD with a C-
terminal His-6 tag was overexpressed in Escherichia coli strain
BL21 (DE3) pLysS. Purification was performed on a NiSO4-
charged HiTrap chelating HP column (Amersham Pharmacia
Biosciences) with elution at 200 mM imidazole. The pooled
fractions were dialyzed overnight in 20 mM TrisHCl (pH
8.0)100 mMNaCl1 mMDTT at 4°C. The protein solution was
concentrated and, after clarification, loaded on a Superdex 200
HR 1030 column(Amersham Pharmacia Biosciences), pre-
equilibrated with the same buffer. PleD appeared as monomer,
and fractions contributing to the peak were pooled. Selenome-
thionine-substituted PleD was expressed by using the metabolic
inhibition pathway. The purification procedure was the same as
for native PleD.
Enzymatic Assays. The assay for the measurement of the initial
velocity of c-diGMP has been described (10). In short, GTP
containing [-32P]GTP (Amersham Pharmacia Biosciences; 5
nCimicroliter) was added to 50 l of a solution containing 12.5
g of PleD in 50 mM TrisHCl (pH 7.8)100 mM NaCl10 mM
MgCl25mM2-mercaptoethanol. Aliquots were taken at regular
time intervals, and the product was assayed by thin-layer chro-
matography. For the product inhibitionmeasurements, PleDwas
preincubated with c-diGMP at 25°C for 5 min. Care was taken
to remove any bound c-diGMP from PleD carried over from the
purification by extensive dialysis.
DGC activity was also assayed indirectly by monitoring the
production of PPi by using an enzyme coupled spectrophoto-
metric assay (16). The reaction mixture contained PleD in 20
mM TrisHCl (pH 8.0)100 mM NaCl5 mM MgCl2100 M
GTP and pyrophosphatase (500milliunitsml). The reaction was
stopped by transferring a 100-l reaction mixture into the
phosphate assay reagent (pH  0; 1 ml final volume) containing
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molybdate and malachite green. The phosphate content in
commercial GTP products had to be reduced from 5% to
0.5% by anion exchange chromatography to reduce back-
ground absorption (17).
Crystallography. Crystals were obtained at room temperature by
hanging-drop vapor diffusion. For this, PleD at a nominal
concentration of 200 M  10 mgml (assuming an 280 of 9200
M1cm1) in 20 mM TrisHCl (pH 8.0)100 mM NaCl1 mM
DTT2 mM MgCl20.8 mM synthetic (10) c-diGMP was mixed
with the reservoir (1.0 M glycine, pH 9.22% dioxane14.5%
polyethylene glycol 20 000) at a ratio of 1:1. Selenomethione-
substituted crystals were obtained in the same manner, but by
using a reservoir solution containing 1.0 M N-tris[hydroxymeth-
yl]methyl-3-aminopropanesulfonic acid (TAPS) (pH 9.0), 2%
dioxane, and 11% polyethylene glycol 20000. Diffraction data
were collected from a single native (15 m in diameter) and a
single Se-Met substituted crystal (60 m) at the Swiss Light
Source, Paul Scherrer Institute, Villigen, Switzerland, and were
processed with MOSFLMSCALA (18). Eighteen selenium posi-
tions were identified by using SHELXD (19). Phase refinement was
performed by SHARPSOLOMON (20) and was followed by two-
fold averaging and phase extension by using DM (21). The model
was built at the interactive graphics and refined by using REFMAC
(18), imposing strict noncrystallographic symmetry constraints
for the two copies in the asymmetric unit except for residues 117,
164, 168, and 404. The entire main chain is defined by electron
density except for residues 137–146, 282–288, and the C-terminal
His-tag.
Results and Discussion
Crystal Structure. The crystal structure of nonphosphorylated
PleD has been solved by multiwavelength anomalous diffrac-
tion phasing on Se-Met substituted protein to 2.7 Å (Tables 1
and 2). The structure shows a linear arrangement of three
structural domains (D1, D2, and DGC; Fig. 1a) that are
connected by single disordered loops. As anticipated, domains
D1 and D2 show the typical RRR fold with ()5 topology.
However, in both domains, the C-terminal helix 5 is consid-
erably extended and protrudes from the globular domain,
apparently enhancing the D1-D2 contact. Both domains
closely resemble each other (rms deviation  1.2 Å for 119
C). Quasiisologous contacts are formed between helix 5 of
one domain and 4, 5, and 5 of the other domain. The
C-terminal extensions of the 5 helices form apolar contacts,
whereas their N-terminal parts are involved in several ionic
interactions with 4 and 5 (Fig. 1b).
Only D1 carries all of the residues required for RRR activation
(11). These are primarily aspartates D9, D10, and the phos-
phoacceptor D53 of the ‘‘acidic pocket’’, but also residues K105,
T83, and F102 that have been shown to undergo large structural
changes upon activation (11). Strong density is bridging the three
carboxylates of the acidic pocket and main-chain carbonyl 55. In
line with its coordination geometry, this has been modeled as a
Mg2 ion. Comparison of D1 with other known RRR structures
confirms that D1 is in the nonactivated conformation with the
4–4 loop in an ‘‘outward’’ orientation. The structural changes
accompanying activation in RRRs are known (22). In Fig. 1b,
(nonactivated) PleD and activated FixJ (23) are superimposed.
From this, one would predict that the largest conformational
change upon PleD activation would occur in the 4–4 loop with
a concomitant shift (1–2 Å) in 4 that participates in the D1–D2
interaction. Another prominent change would be a rotameric
switch of F102. Aromatic residues in this position have been
shown to swing from a half-buried location into a pocket between
4 and the -sheet that opens up on activation (11, 23). Notably
Table 1. Crystallographic data
Native
SeMet
Peak Inflection Remote
Data collection
Wavelength, Å 0.97950 0.97950 0.97970 0.97700
Resolution, Å 2.7 3.2 3.0 3.0
Highest shell, Å 2.85–2.70 3.27–3.20 3.16–3.00 3.16–3.00
Space group P42212
a  b, Å 135.9 134.9
c, Å 169.2 168.1
No. of unique reflections 42,707 26,249 32,080 32,140
Redundancy 5.7 (5.5) 4.1 (3.9) 4.8 (4.9) 4.6 (3.6)
I 7.2 (1.9) 6.2 (2.1) 7.2 (1.8) 7.3 (1.1)
Completeness, % 99.3 (98.7) 99.9 (100) 99.9 (100) 99.6 (97.6)
Anom. completeness, % — 99.7 99.9 97.5
Rmerge, % 8.3 (36) 10.5 (33) 9.4 (39) 11.0 (63)
Phasing
Resolution shell 13.12 7.69 5.98 5.06 4.47 3.72 3.46 3.16
Figure of merit 0.74 0.67 0.62 0.55 0.50 0.34 0.27 0.13
Mean figure of merit 0.39
Values in parentheses are for the highest-resolution shell.
Table 2. Model statistics
No. of molecules in a.u. 2
Resolution, Å 50.0–2.7
RRfree, % 21.023.9
rms deviation
Bond lengths, Å* 0.008
Bond angles, °* 1.2
rms B of bonded atoms, Å2
Main chain 1.13
Side chain 2.42
Protein atoms 6883
Water molecules 15
Ligand atoms 233
Residues in Ramachandran core, % 92.8
Residues in disallowed region, % 0.0
Average B, Å2 25.6
*rms deviation from ideal stereochemistry.
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and similar to CheB (24), F102 is located at a central position of
the interface (Fig. 1b). This argues for a repacking of the D1–D2
interface upon phosphorylation. How this may tie in with a
global model of PleD activation is discussed below.
The DGC (GGDEF) domain consists of a five-stranded
central -sheet surrounded by helices (Fig. 1a). Discounting two
additional short -hairpins (0, 0 and 3, 3) and the
N-terminal helix 0, the succession of secondary structure
elements is (), for which the topology is identical
and the arrangement closely similar to that of the catalytic core
of adenylate cyclase (AC) (25) as well as to the ‘‘palm’’ domain
of DNA polymerases (26) (Fig. 5, which is published as sup-
porting information on the PNAS web site). Structural related-
ness with AC has been proposed earlier by sequence threading
(27). Obviously, the DGC domain is functionally related to AC
and DNA polymerases in that it also catalyzes 3–5 phosphodi-
ester formation. The GG(DE)EF signature motif locates to the
central -hairpin (Fig. 1a), which, as in AC and DNA poly-
merases, constitutes part of the active site.
In the crystal, PleD monomers are arranged to local dimers
(Fig. 1c). Isologous contacts are formed, with Y26 of D1 being
tucked between helices 3 and 4 of D2 and the N terminus
contacting 3. The small contact area (2  425 Å2) is consistent
with the monomeric state of PleD in solution. Along the
direction of their symmetry axis, dimers are associated head to
head to form tetramers of 222 symmetry. Intriguingly, this
interaction does not involve protein–protein contacts. Instead, as
shown in Fig. 2a, c-diGMP is bound with its two guanine bases
in a two-fold symmetric fashion to the active site formed by the
adjacent monomers. This crosslinking of adjacent dimers rep-
resents a serendipitous crystallization artifact, because it pro-
vides comprehensive information about the product–enzyme
interactions that appears relevant also for the situation in
solution where the product would bridge the catalytic domains
within a dimer (see below).
Active Site and Catalytic Mechanism. Fig. 2b shows that the guanine
base is inserted in a pocket formed mainly by helices 1 and 2
of DGC. All of its polar atoms except O6 make specific
interactions, explaining the observed GTP versus ATP discrim-
ination (10). The N335 side chain forms H-bonds with N3 and
N2, whereas N1 is recognized by the D344 carboxylate. Both
residues are highly conserved among DGC domains. Further-
more, the base abuts the apolar side chains of L294, F331, and
L347. The ribosyl and the -phosphate are extending over the
turn of the 2-3-hairpin, with G369 being completely covered,
explaining glycine conservation at this position. The 2-hydroxyl
is H-bonded to N335, and a phosphate nonester oxygen is in the
vicinity of the main-chain amide 369.
On the basis of the observed complex structure, extrapolations
regarding the binding mode of the GTP substrate to an indi-
vidual DGC domain as well as the catalytic mechanism can be
proposed (Fig. 2c). Considering the specific interactions with the
protein, it is most likely that the guanyl base does not change its
position during catalysis. Furthermore, we assume that the
ribosyl and -phosphate moieties largely keep their positions. In
this case, the - and -phosphates of the substrate would be
easily accommodated close to G368 of the -hairpin and would
probably be bound via a Mg2 ion to E371, with R300 conferring
further stabilization. For catalysis to occur, two substrate-loaded
DGC domains have to arrange themselves in a similar way like
the interdimer crosslink in the crystal (Fig. 2 b and c). This might
of the asymmetric unit form a two-fold dimer. The view is related by a 60°
rotation about the dimer (vertical) axis with respect to the view in a. The
c-diGMP molecules that are bound to sites A and A crosslink to another dimer
above (see Fig. 2a).
Fig. 1. Crystal structure of PleD. (a) The monomer consists of three domains
connected by disordered linker peptides (light gray). Domains D1 (residues
2–140, red) and D2 (residues 141–285, yellow) show the CheY-like fold. D1
carries the phosphoacceptor D53. The catalytic DGC domain (286–454) is
shown in green. The GGEEF signature motif is located on the -hairpin (blue)
and constitutes part of the active site (A-site) to which a c-diGMP molecule is
bound. Two c-diGMP molecules are found at the D2DGC interface (I-site). (b)
The D1(red)D2(yellow) interface as viewed along the quasi-two-fold axis.
Compared with the view in a, the structure has been rotated by 90° approx-
imately around the horizontal. Ionic residues in the interface and residues
implicated in activation (phosphoacceptor D53, K105, T83, and F102) are
shown. The trace of the4-4 loop and F101 of phosphorylated FixJ [magenta;
PDB ID code 1d5w (23)] is shown superimposed on D1. (c) The two monomers
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be facilitated by charge complementarity between D336 and
R300 (Fig. 2b). Subsequently, the 3-OH group of the GTP
substrate has to be deprotonated to allow an intermolecular
nucleophilic attack onto the -phosphate. E370 appears well
poised for acting as a general base, whereas K332 would stabilize
the charge of the developing pentacoordinated phosphoryl
transition state and the pyrophosphate leaving group. All of the
residues proposed to be of functional importance are highly
conserved among DGC sequences.
Intriguingly, the proposed nucleotide-binding mode is differ-
ent from that observed in AC (Fig. 2d) and DNA polymerases.
In both enzymes, the phosphate-binding site is provided by the
short P-loop between 1 and 1. In AC, the base is lying on the
-hairpin and is recognized by residues of the second subunit of
the heterodimer, whereas in DNA polymerases the base adopts
even another position, which allows base pairing with the
template strand (28). Is it conceivable that DGC can bind the
substrate in a similar way as AC? This appears unlikely, because
there would be no interactions with the base conferring speci-
ficity and contributing to binding affinity. An alternative model
with the base bound to the DGC guanine-binding pocket and the
terminal phosphates bound to the P-loop appears sterically
unfeasible. Thus, there seems to be no reasonable alternative to
the proposed model of the substrate–DGC complex, which
nevertheless has to be confirmed experimentally. In AC, a
magnesium ion coordinated by two aspartates (D396 and D440;
Fig. 2d) has been proposed to assist in the nucleophilic attack of
the 3-OH group onto the -phosphate (25). Conspicuously, the
DGC domain exhibits two invariant acidic residues (D327, E370)
at very similar positions, but there is no indication for a bound
Fig. 2. Ligand binding to the active site of PleD. (a) Dimers are packed head-to-head to form 222 tetramers. The view is rotated by 135° about the vertical axis
with respect to Fig. 1c. The dimers are held together by two c-diGMP ligands that are located on a local two-fold axis of the tetramer (the viewing direction),
the ligand molecule in the back has been omitted for clarity. (b) Stereographic close-up view of a. The G368GEEF signature motif comprises residues important
for substrate binding (G368, G369, and E371) and catalysis (E370). The omit map of the ligand is contoured at 4 . The side chains of E370, E371, R300, K332, and
D336 are partly disordered. (c) Complex of DGC with substrate GTP-Mg as modeled on the basis of the product complex shown in b. The positions of the guanine,
ribose, and -phosphoryl moieties are the same as in the product complex structure. The upper substrate, which has been shifted arbitrarily by2 Å to the upper
right, would be bound to another two-fold related DGC domain (not shown). The side-chain conformations of E370 and K332 have been adjusted to bring the
functional groups into catalytically competent positions. The arrows indicate the nucleophilic attack of the 3-oxygens on the -phosphates. (d) AC in complex
with substrate analog ATP--S [light-blue, PDB ID code 1cjk (25)], view corresponding to that in c. The C-trace corresponds to that part of the -chain, which
is structurally homologous to DGC. The -chain, which provides specific interactions with the adenine base, has been omitted for clarity.
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metal, which is in line with the disorder of E370. In fact, a
magnesium ion coordinated by these residues would be too
distant from the substrate to be effective. E370 is proposed to act
as a general base (see above), but the role of D327, if any,
remains to be elucidated.
Allosteric Site and Product Inhibition. Unexpectedly, the crystal
structure shows two product molecules bound to the D2DGC
interface (I-site; Figs. 1 and 3). The dimeric ligand is of compact
roundish shape with mutually intercalated purine bases. Each of
the two central guanyl moieties forms an intermolecular H-bond
with a phosphate group. A similar structure has been observed
for several crystal forms of c-diGMP (29, 30) and may be present
also in solution. The ligand is bound to both D2 and DGC by a
multitude of specific interactions. Hereby the common base–
arginine pairing motif involving O6 and N7 of the guanyl (31)
occurs three times (with R390, R359, and R178; Fig. 3b). Tight
binding is consistent with the observed copurification of c-
diGMP during protein preparation. Intriguingly, kinetic data
reveal strong product inhibition, with a Ki (0.5 M; Fig. 6, which
is published as supporting information on the PNAS web site)
about an order of magnitude lower than estimated for the
cellular concentration of c-diGMP (32). Clearly, inhibition is
noncompetitive (Fig. 6), i.e., independent of substrate concen-
tration, and can thus be attributed to an allosteric effect of I-site
binding.
Fig. 4. Mechanistic model of PleD regulation. The catalytic DGC domain (green) is tethered via a flexible linker peptide to the D1D2 stem. The DGC domain
is postulated to be mobile with respect to the stem, as indicated by the curved broken arrow. (Upper) PleD is activated by phosphorylation at the D1 domain,
which induces dimerization mediated by the stems and allows the two substrate-binding sites (with bound GTP substrate in yellow) to approach each other and
the condensation reaction (2 GTP3 c-diGMP 2 PPi) to occur. (Lower) Allosteric product inhibition occurs by binding of (c-diGMP)2 to the I-site at the stem–DGC
interface, whereby the DGC domain is immobilized with respect to the stem and barred from approaching its counterpart in the dimer.
Fig. 3. Product binding to the allosteric inhibitory I-site. (a) A close-up view of the two mutually intercalated c-diGMP molecules (khaki and gray carbon atoms)
bound at the D2 (yellow)–DGC (green) interface. The omit map of the ligand is contoured at 4 . (b) The ligand is tightly bound to both domains [carbons are
colored in magenta (D2) and cyan (DGC)] by a multitude of specific interactions, including a recurrent arginine–guanine-binding motif. Figures were generated
by DINO (A. Philippsen, www.dino3d.org).
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Mechanistic Model of Regulation. PleD catalyzes a condensation
reaction of two identical substrates (that are bound to two
identical DGC domains) to yield a C2-symmetric product mol-
ecule. In solution, nonactivated PleD appears to be monomeric,
as determined by analytical ultracentrifugation and gel filtration
(not shown). For the enzyme to be efficient, dimerization
appears necessary, because a reaction catalyzed by monomeric
PleD would be severely limited by the macromolecular diffusion
rate. Based on this reasoning, a simple mechanistic model of
activation and product inhibition can be proposed (Fig. 4).
Phosphorylation at D53 of D1 would induce repacking of the
D1D2 interface and reorientation of D1 with respect to D2.
This in turn will enhance dimer formation mediated by isologous
D1-D2 contacts across the interface. In fact, the dimeric struc-
ture of nonactivated PleD in the crystal may well resemble the
active dimer, although with a suboptimal interface. This view is
supported by the lack of activity of N-terminally His-tagged PleD
(data not shown), which would be due to interference of the tag
with the interface (Fig. 1c). The low constitutive activity ob-
served in vitro (10) would thus be due to a small fraction of
nondissociated dimers. Consistent with this, the specific activity
shows a strong dependence on the enzyme concentration (un-
published data).
The large distance between the substrate-binding sites of the
crystal dimer (Fig. 1c) would not permit catalysis. However,
allowing for flexibility of the DGC domains relative to the stem
(a realistic assumption considering the small D2DGC interface
area of 690 Å2), a ‘‘closed’’ dimer conformation competent for
catalysis can be readily modeled (schematically shown in Fig. 4),
in which a complete two-fold symmetric active site is formed as
observed for the DGCDGC pair (Fig. 2b). In the context of
this activation-by-dimerization model, the observed allosteric
product inhibition can easily be explained (Fig. 4). Stabilization
of the D2DGC interface by product binding to the I-site would
simply prevent encounter of the substrate-binding sites (inhibi-
tion by domain immobilization).
The tight feedback regulation of PleD by product inhibition
probably demonstrates the importance of imposing an upper
limit on the concentration of the second messenger c-diGMP. It
remains to be shown that, as predicted by the model, inhibition
indeed constitutes an overriding principle, i.e., that inhibition is
independent of the phosphorylation state of the enzyme. The
structure of PleD provides insight into themolecular interactions
with c-diGMP that may recur in the recognition of this ligand by
other proteins. The quest for downstream targets of this mes-
senger that appears to be ubiquitous in prokaryotes (6) has
started.
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